In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris

Positive correlation between Candida auris skin-colonization burden and environmental contamination at a ventilator-capable skilled nursing facility in Chicago

(2021) D Joseph Sexton et al.   CLINICAL INFECTIOUS DISEASES

Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities

(2021) Suhail Ahmad et al.   Microorganisms

In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa

(2021) Tsidiso G. Maphanga et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris

(2020) Jeffrey M. Rybak et al.   mBio

Candida auris candidaemia in an intensive care unit – Prospective observational study to evaluate epidemiology, risk factors, and outcome

(2020) Prakash S. Shastri et al.   JOURNAL OF CRITICAL CARE

Correction for Lombardi et al., “Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species”

(2020) Lisa Lombardi et al.   mSphere

Autonomously Replicating Linear Plasmids That Facilitate the Analysis of Replication Origin Function in Candida albicans

(2019) Swati Bijlani et al.   mSphere

Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species

(2019) Lisa Lombardi et al.   mSphere

Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris

(2019) Jeffrey M. Rybak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria

(2019) Mark J Biagi et al.   Open Forum Infectious Diseases

Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs

(2019) Suhail Ahmad et al.   MYCOSES

A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance

(2018) Anuradha Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Limited ERG11 Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole Susceptibility

(2018) Kelley R. Healey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ERG6 and ERG2 are major targets conferring reduced susceptibility to amphotericin B in clinical Candida glabrata isolates in Kuwait

(2018) Suhail Ahmad et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species

(2018) José F. Muñoz et al.   Nature Communications

Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

(2016) Shawn R. Lockhart et al.   CLINICAL INFECTIOUS DISEASES

Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital

(2009) Kazuo Satoh et al.   MICROBIOLOGY AND IMMUNOLOGY